ACTRN12618000812291尚未招募4 期
Vedolizumab trough levels following randomised withdrawal of immunomodulator in ulcerative colitis patients in remission
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Monitoring of Vedolizumab Infusion Therapy response with fecal calprotectin, ultrasound and trough serum level in Ulcerative colitis. A multicentric, prospective non-interventional StudyK51Ulcerative colitisDRKS00014249Internistische Gemeinschaftspraxis50
招募中
不适用
Prospective evaluation of vedolizumab-effects and safety in patients with inflammatory bowel diseases (VED IBD Cohort Study)JPRN-UMIN000040175Saitama Medical Center, Saitama Medical University50
已完成
不适用
Prospective evaluation of vedolizumab-effects in patients with inflammatory bowel diseasesulcerative colitis and Crohn's diseaseJPRN-UMIN000039916Saitama Medical Center, Saitama Medical University50
已完成
不适用
Therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel diseaseNL-OMON55193Maxima Medisch Centrum160
尚未招募
不适用
Therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel diseaseNL-OMON28041one160